GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3951 - 3975** of **4050** in total

« First

‹ Prev

…

155

156

157

158

159

160

161

162

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G96881BQ	65
IgM	Patient 3	-180	mild	G96881BQ	109
IgA	Patient 3	4	mild	G96881BQ	430
IgG	Patient 3	11	mild	G96881BQ	58
IgG	Patient 3	4	mild	G96881BQ	50
IgM	Patient 3	11	mild	G96881BQ	141
IgM	Patient 3	4	mild	G96881BQ	139
IgA	Patient 4	12	mild	G96881BQ	382
IgG	Patient 4	12	mild	G96881BQ	117
IgM	Patient 4	12	mild	G96881BQ	252
IgA	Patient 1	10	moderate	G98068PA	383
IgA	Patient 1	22	moderate	G98068PA	351
IgA	Patient 1	6	moderate	G98068PA	291
IgG	Patient 1	10	moderate	G98068PA	22
IgG	Patient 1	22	moderate	G98068PA	27
IgM	Patient 1	10	moderate	G98068PA	34
IgM	Patient 1	22	moderate	G98068PA	98
IgA	Patient 2	15	mild	G98068PA	447
IgA	Patient 2	24	mild	G98068PA	484
IgG	Patient 2	15	mild	G98068PA	38
IgG	Patient 2	24	mild	G98068PA	38
IgM	Patient 2	15	mild	G98068PA	121
IgG	Patient 1	6	moderate	G98068PA	24
IgM	Patient 1	6	moderate	G98068PA	39
IgA	Patient 2	3	mild	G98068PA	501